Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
200,691,838
-
Share change
-
-5,857,215
-
Total reported value
-
$87,287,919,928
-
Put/Call ratio
-
65%
-
Price per share
-
$434.96
-
Number of holders
-
1,638
-
Value change
-
-$2,163,798,151
-
Number of buys
-
847
-
Number of sells
-
664
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2025
As of 31 Mar 2025,
Elevance Health, Inc. - Common Stock (ELV) was held by
1,638 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
200,691,838 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, Sanders Capital, LLC, Artisan Partners Limited Partnership, and First Eagle Investment Management, LLC.
This page lists
1,641
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.